Medical Marijuana: Mississippi Ballot Initiative 2020

What the research says:

  • A recent report from the National Academy of Science, Engineering, and Medicine suggested that conclusive or substantial evidence exists for the use of cannabis, or marijuana, as an effective treatment for chemotherapy-induced nausea, and chronic pain.
  • A recent systematic review and meta-analysis conducted by researchers in the department of Epidemiology and Psychiatry at Columbia University found no significant association between Medical Marijuana Programs (MMPs) and child marijuana use prevalence.
  • Research has indicated that higher levels of Tetrahydrocannabinol (THC) and chronic marijuana use have been linked with certain psychiatric conditions, including the risk of developing cannabis use disorder (CUD), or marijuana addiction.
  • Research has indicated that MMP participants report improvement in overall health status, specifically reductions in levels of risky alcohol consumption, and illegal drug use.
  • Research has linked marijuana to increased risk for motor vehicle accidents and accidents in general.

The ballot measure:

  • The Mississippi State Department of Health (MSDH) will be the agency responsible for the entirety of the preparation and roll-out of the state’s MMP if the ballot measure passes.

The Center for Mississippi Health Policy has produced an issue brief that summarizes the research on the impact of Medical Marijuana Programs and examines policy considerations. To view the source appendix click here with source citations. There are links to both documents in the sidebar at the left of this page.  Printed copies of the brief and report can be obtained by contacting the Center for Mississippi Health Policy at 601-709-2133 or by e-mail at info@mshealthpolicy.com.